BIO is glad to hear that the American Society for Biochemistry and Molecular Biology (ASBMB) is helping the biotech community by promoting diversity. ASBMB has put forth a number of recommendations in response to an alarming 2011 NIH study showing that black researchers were 10% less likely to receive funding than white researchers. These suggestions all aim to ease access to resources and educate minority scientists on how to succeed in the research community- read more about what ASBMB has to say in this article from their monthly publication.
Here at BIO, we are doing our part to bring together leaders of industry, education, and government at our Diversity Summit, to be held in conjunction with the BIO International Convention, taking place June 18-21, 2012 at the Boston Convention and Exhibition Center in Boston, MA.
Moderator Dr. Louis W. Sullivan, Former Secretary of Health and Human Services, President Emeritus, Morehouse School of Medicine, explains the importance of diversity in biotechnology: “A more diverse scientific workforce, racially and ethnically, will help to insure that the full potential of talent for discovery and innovation in America will be developed, strengthening our scientific disciplines and enhancing discovery, leading to greater economic prosperity and to healthier lives for Americans and others around the world.”
We are excited to be part of this exchange of ideas, and invite interested parties to come hear our panel of experts discuss current issues, examine where we are today, and propose strategies for improvement. See you in Boston!
Listen to a podcast preview of the Diversity Summit with Dr. Brandi Kaye Freeman, Robert Wood Johnson Clinical Scholar and Past Trustee to the Board of Trustees of the National Medical Association (NMA).